(Total Views: 340)
Posted On: 01/10/2019 11:39:56 AM
Post# of 4611
quoting OTC Markets .. which is a for profit site .. with all that that implies is beyond telling
NR has significant issues with IPIX (stock)
NR has brutalized IPIX (stock) to impact Innovation Pharma's (company)
ability to execute .. and to get actual investors (not embeds or trading crews
that infest various SMBs) to sell .. the hand off was from EO 2014 into 2015
NR had a significant YTD *volume* issue re: IPIX which revealed itself by the EO August 2018
NR *adjusted* that *volume* issue on 9.12.18 .. (K was filed AH's on 9.11.18 and clearly NRs' algos had gleaned term sheet input from the K's filing) which resulted in beyond bizarre IPIX *volume* engendered in the last 4 months of 2018
ihang isn't ihub .. embeds and multi/s (NRs' seemingly limitless pockets) are easily picked off *here* vs *there*
Innovation Pharma (company) has 3 things most OTC targets don't
a diverse platform .. actual retail investors .. and an aware mgmt
4kids
NR has significant issues with IPIX (stock)
NR has brutalized IPIX (stock) to impact Innovation Pharma's (company)
ability to execute .. and to get actual investors (not embeds or trading crews
that infest various SMBs) to sell .. the hand off was from EO 2014 into 2015
NR had a significant YTD *volume* issue re: IPIX which revealed itself by the EO August 2018
NR *adjusted* that *volume* issue on 9.12.18 .. (K was filed AH's on 9.11.18 and clearly NRs' algos had gleaned term sheet input from the K's filing) which resulted in beyond bizarre IPIX *volume* engendered in the last 4 months of 2018
ihang isn't ihub .. embeds and multi/s (NRs' seemingly limitless pockets) are easily picked off *here* vs *there*
Innovation Pharma (company) has 3 things most OTC targets don't
a diverse platform .. actual retail investors .. and an aware mgmt
4kids
(1)
(0)
